Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

Feb 13, 2020

30561_dirs_2020-02-12_80ce606f-dab0-47f1-8035-3b4dd4137842.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-02-11

Reporting Person: SCANGOS GEORGE A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-11 Common Stock S 4000 $20.14 Disposed 1034031 Direct
2020-02-12 Common Stock S 21000 $20.02 Disposed 1013031 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8963 Indirect
Common Stock 8963 Indirect
Common Stock 5669 Indirect

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.35. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.08. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

F4: Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.

F5: Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.

F6: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 10, 2020.